Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial (MOVE-JIA)
Optimizing Treatment for Children and Adolescents With Juvenile Idiopathic Arthritis in Sustained Remission: a Comparison of Three Treatment Strategies. The MOVE-JIA Trial
Sponsor: Oslo University Hospital
This PHASE4 trial investigates Juvenile Idiopathic Arthritis and is currently actively recruiting participants. Oslo University Hospital leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Jun 2025 — Present [monthly]
Recruiting PHASE4
-
Apr 2025 — Jun 2025 [monthly]
Recruiting PHASE4
-
Dec 2024 — Apr 2025 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Nov 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE4
First recorded
Oct 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oslo University Hospital
- Remedy
- South-Eastern Norway Regional Health Authority
- The Research Council of Norway
For direct contact, visit the study record on ClinicalTrials.gov .